Please login to the form below

Not currently logged in
Email:
Password:

Natco Pharma

This page shows the latest Natco Pharma news and features for those working in and with pharma, biotech and healthcare.

Teva faces early rival to longer-acting Copaxone in US

Teva faces early rival to longer-acting Copaxone in US

the importance Copaxone (glatiramer acetate) has to the Israeli pharma group’s finances. ... The approval and launch is also big news for Indian company Natco Pharma, which partnered with Mylan on developing the generic and will share profits on sales.

Latest news

  • India turns down patent on Gilead's Sovaldi India turns down patent on Gilead's Sovaldi

    Last year, Sovaldi's Indian intellectual property (IP) also faced a "pre-grant" objection from domestic pharma company Natco as well as the New York-based Initiative for Medicines, Access &Knowledge ... The Indian ruling suggests other drugmakers like

  • BMS says it defends Sprycel patent in India BMS says it defends Sprycel patent in India

    BDR had been trying to secure a compulsory license to overturn BMS' 2010 Indian patent on Sprycel on the grounds of public need, a strategy which allowed Natco Pharma to start ... Towards the end of last year court documents suggested Natco was no longer

  • Bayer fails to overturn Nexavar compulsory licence in India Bayer fails to overturn Nexavar compulsory licence in India

    Natco Pharma allowed to sell cut-price version of cancer drug. Bayer's first attempt at overturning a compulsory license in India for its cancer drug Nexavar was knocked back yesterday ... The Intellectual Property Appellate Board (IPAB) upheld the

  • India could hit Roche and BMS with compulsory licences India could hit Roche and BMS with compulsory licences

    The first compulsory licence in India was introduced last year for Bayer's liver cancer drug Nexevar (sorefinib), allowing Natco Pharma to sell a copy of the treatment that was 95 ... It is a very good move and will not just benefit Indians but possibly

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...